Keystone Folding Box Co. and Med-Con Technologies have partnered to integrate Med-Con's digital adherence monitoring ...

A new study from Finland has found that children with attention-deficit/hyperactivity disorder often stay on medication for ...

Keystone Folding Box Co., a provider of paperboard packaging solutions, has partnered with Med-Con Technologies, a provider ...

This study aimed to determine whether coaching or smartphone reminder interventions could reduce all-cause hospital re-admission within six months of randomization, medication adherence to ...

Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...

After three years, only about 1 in 12 individuals taking GLP-1s to treat obesity remained on the therapy, according to a Prime Therapeutics study published on June 25. Prime is owned by 19 Blue Cross ...

The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

In an early look at SCOT-HEART 2, CCTA led more primary-prevention patients to make changes to reduce their risk of CVD.

GLP-1 obesity drug use is rising, but long-term adherence remains low. While one-year persistence has improved in 2024, only ...

Defect-free quadruple medication therapy significantly improved at discharge, 30 days in patients with heart failure with reduced ejection fraction.